Status:
UNKNOWN
Next Generation Sequencing in Intrahepatic Cholangiocarcinoma
Lead Sponsor:
University of Bologna
Conditions:
Intrahepatic Cholangiocarcinoma
Eligibility:
All Genders
18+ years
Brief Summary
The aim of the present study is to perform a comprehensive molecular characterization of intrahepatic cholangiocarcinoma (ICC) in patients exposed to well-known or putative risk factors (such as asbes...
Detailed Description
Exposure to distinct risk factors of the enrolled ICC patients will be assessed by modified ReNaM questionnaire. Molecular characterization of ICC tissue samples will be carried out by RNAseq. Briefly...
Eligibility Criteria
Inclusion
- patients having a confirmed diagnosis of ICC resected;
- patients who have signed the informed consent;
- patients (males or females) who are at least 18 years old.
Exclusion
- patients who have been treated with any medical treatment (chemotherapy or experimental standard) or with radiotherapy during the last 5 years.
Key Trial Info
Start Date :
May 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 1 2017
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT02184871
Start Date
May 1 2014
End Date
May 1 2017
Last Update
July 9 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Policlinico S.Orsola- Malpighi, S.S.D. Oncologia Medica- Biasco
Bologna, BO, Italy, 40138